As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” ...

International price referencing for certain drugs could be revisited during the second Trump administration. But it's ...

The nonprofit health system’s new partnership with the Mark Cuban Cost Plus Drug Co. marketplace for businesses officially goes into effect in January. The marketplace is part of Cuban’s larger ...

Mark Cuban Cost Plus Drug Co. has seen exponential growth since its launch, supplying thousands of healthcare facilities with discounted generics in shortage.

The Penn Medicine partnership with Mark Cuban's Cost Plus Drug Co. is designed to cut the health system's drug costs and improve access to prescription medicines. Penn Medicine has entered into a ...

Penn Medicine has enlisted Mark Cuban Cost Plus Drug Company to secure key generics for its retail pharmacy network. Penn will lean on the Cost Plus Marketplace for 100 of the most frequently ...

Billionaire entrepreneur Mark Cuban has been vocal about reshaping the U.S. health care system for years. During recent ...

thanks to a new alliance between PharmPix and Mark Cuban Cost Plus Drug Company (Cost Plus Drugs). With over 90% of prescribed drugs in the U.S. being generics, PharmPix and Cost Plus Drugs are ...

If all drug manufacturers would sell to Cost Plus Drugs at a competitive price, then all drugs would be available at cost plus 15%, and the amount of money spent on drugs would decline ...

To reduce medication costs and mitigate drug shortages, Penn Medicine is uniting with Mark Cuban Cost Plus Drug Co., the health system said Dec. 6. The Philadelphia-based organization will buy the ...

UNITED STATES, — The start of 2025 marks the start of the capping of prescription drug costs for Medicare Part D recipients.